Free Trial

Daniel Arias - Stifel Nicolaus Analyst Performance

This page shows the methodology used to calculate Daniel Arias's recommendation performance. Listed below are links to the research notes issued, the price targets issued by the analyst, and the stock's actual price 12 months from the date the research note was issued. These rankings are based on research reports from . Rankings are updated daily.

MarketBeat Analyst Ranking:
Average 12-Month ROI of Buy and Strong Buy Recommendations: ???%

CompanyReport DateReport Date Price12-Month
Price Target
Rating12-Month
Actual Price
12-Month
ROI
Details
Revvity Inc. stock logo
RVTY
Revvity
7/29/2025$95.66$110.00Hold???%???%
Bruker Corporation stock logo
BRKR
Bruker
5/8/2025$40.95$48.00Hold???%???%
Bio-Techne Corp stock logo
TECH
Bio-Techne
5/8/2025$48.76$60.00Hold???%???%
Guardant Health, Inc. stock logo
GH
Guardant Health
5/1/2025$48.06$60.00Buy???%???%
Avantor, Inc. stock logo
AVTR
Avantor
4/28/2025$12.93$14.00Hold???%???%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
4/24/2025$422.94$620.00Buy???%???%
Danaher Corporation stock logo
DHR
Danaher
3/14/2025$203.96$260.00Buy???%???%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
3/12/2025$3.47$9.00Buy???%???%
Guardant Health, Inc. stock logo
GH
Guardant Health
2/21/2025$45.85$53.00Buy???%???%
Bruker Corporation stock logo
BRKR
Bruker
2/14/2025$50.29$57.00Hold???%???%
10x Genomics stock logo
TXG
10x Genomics
2/13/2025$11.52$18.00Buy???%???%
Avantor, Inc. stock logo
AVTR
Avantor
2/10/2025$19.15$26.00Buy???%???%
Berkeley Lights, Inc. stock logo
BLI
Berkeley Lights
1/6/2022$16.27$12.00Sell???%???%
Codexis, Inc. stock logo
CDXS
Codexis
6/18/2021$20.82$30.00Buy???%???%
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
4/2/2020$58.12$90.00Buy???%???%
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
2/14/2020$98.18$110.00Buy???%???%
Illumina, Inc. stock logo
ILMN
Illumina
10/11/2016$184.85$140.00Neutral???%???%
Illumina, Inc. stock logo
ILMN
Illumina
9/12/2016$164.85$190.00Buy???%???%


Return to Analyst Rankings